Dialog Box

Ovarian Cancer Australia in the News View all news

Teal Tribe

Diagnosed with Stage 3 advanced ovarian cancer at the age of 41, Renata shared her story with parliamentary ambassadors at Parliament House.

Media Releases

Pharmaceutical Benefits Advisory Committee (PBAC) has also now recommended the PARP inhibitors Olaparib and Niraparib be listed on the PBS for those with HRD.

Media Releases

Ovarian Cancer Australia and TerryWhite Chemmart forge ahead in their 17-year partnership, united in the quest to save lives.

Media Releases

Submissions to Medical Services Advisory Committee advocating for access to two funded HRD in Australia have been recommended.